Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk: a single-center study

Detalles Bibliográficos
Autores principales: Chai, Meng, Zhang, Haitao, Yang, Lixia, Liang, Jing, Han, Hongya, Liu, Xiaoli, Ma, Xiaoteng, Liu, Yan, Shi, Dongmei, Zhao, Yingxin, Liu, Yuyang, Zhou, Yujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Clinical Observation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309505/
https://www.ncbi.nlm.nih.gov/pubmed/37185356
http://dx.doi.org/10.1097/CM9.0000000000002399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309505/
https://www.ncbi.nlm.nih.gov/pubmed/37185356
http://dx.doi.org/10.1097/CM9.0000000000002399

Ejemplares similares